Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
COVID-19 convalescent plasma (1 trial)
Communicable Diseases (Phase 3)
Coronavirus Infections (Phase 3)
Infections (Phase 3)
RNA Virus Infections (Phase 3)
Severe Acute Respiratory Syndrome (Phase 3)
Virus Diseases (Phase 3)
Trials (1 total)
Trial APIs (1 total)